Imraldi 40 mg/0.8 ml

Imraldi 40 mg/0.8 ml is a medicine authorised by Swissmedic under authorisation number 67582. The authorisation holder is Samsung Bioepis CH GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 April 2020 and the authorisation is valid without a time limit. ATC code L04AB04 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 67582
  • ATC L04AB04
  • Biotechnological medicines
Authorisation data
Authorisation number67582
NameImraldi 40 mg/0.8 ml
Full nameImraldi 40 mg/0.8 ml, Injektionslösung im Fertigpen
Authorisation holderSamsung Bioepis CH GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AB04
First authorisation03 April 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Imraldi 40 mg/0.8 ml, Injektionslösung im FertigpenB03 April 2020
2Imraldi 40 mg/0.4 ml, Injektionslösung im FertigpenB18 December 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Injektor(en), vorgefüllt/PenL04AB0407.15.0.B
22Injektor(en), vorgefüllt/PenL04AB0407.15.0.B
36Injektor(en), vorgefüllt/PenL04AB0407.15.0.B
41Injektor(en), vorgefüllt/PenL04AB0407.15.0.B
52Injektor(en), vorgefüllt/PenL04AB0407.15.0.B
66Injektor(en), vorgefüllt/PenL04AB0407.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Imraldi 40 mg/0.8 ml authorised in Switzerland?

Yes. Imraldi 40 mg/0.8 ml is authorised by Swissmedic under authorisation number 67582, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Imraldi 40 mg/0.8 ml have?

Imraldi 40 mg/0.8 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Imraldi 40 mg/0.8 ml?

The authorisation holder is Samsung Bioepis CH GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com